XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Beginning balance at Jan. 31, 2021 $ (35,425) $ 2 [1] $ 133,406 $ 57 $ (168,890) $ 81,523 [1]
Beginning balance, shares at Jan. 31, 2021 [1]   16,582,525       77,696,679
Issuance of common stock upon exercise of stock options 375   375      
Issuance of common stock upon exercise of stock options, shares [1]   1,404,966        
Issuance of common stock upon exercise of common stock warrants (Share) [1]   233,578        
Issuance of common stock upon exercise of common stock warrants 3   3      
Stock-Based Compensation 1,765   1,765      
Foreign currency translation gain (loss) (5)     (5)    
Net loss, as restated (38,241)       (38,241)  
Ending balance at Dec. 31, 2021 (71,528) $ 2 [1] 135,549 52 (207,131) $ 81,523 [1]
Ending balance, shares at Dec. 31, 2021 [1]   18,221,069       77,696,679
Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination 81,523 $ 6 [1] 81,517     $ (81,523) [1]
Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination, shares [1]   57,380,563       (77,696,679)
Issuance of common stock upon exercise of stock options $ 1,020   1,020      
Issuance of common stock upon exercise of stock options, shares 2,768,568 2,768,568 [1]        
Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated $ 159,538 $ 3 [1] 159,535      
Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated, shares [1]   34,850,706        
Issuance of common stock upon release of RSUs (Share) [1]   7,046,689        
Issuance of common stock upon release of RSUs   $ 1 [1] (1)      
Issuance of common stock pursuant to the Common Stock Purchase Agreement (Share) [1]   171,008        
Issuance of common stock upon exercise of common stock warrants (Share) [1]   4,818,630        
Issuance of common stock upon exercise of common stock warrants 5,048   5,048      
Reclassification of loan and security agreement warrants to equity 6,370   6,370      
Stock-Based Compensation 44,812   44,812      
Settlement of the first tranche of forward contract (3,305)   (3,305)      
Capitalization of deferred costs to equity upon share issuance (1,520)   (1,520)      
Foreign currency translation gain (loss) 101     101    
Change in unrealized loss on available-for-sale securities (314)     (314)    
Net loss, as restated (71,521)       (71,521)  
Ending balance at Dec. 31, 2022 $ 150,224 $ 12 [1] $ 429,025 $ (161) $ (278,652)  
Ending balance, shares at Dec. 31, 2022 113,810,285 125,257,233 [1]        
[1] Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible
Series C-1
Preferred Stock, legacy Class A Common Stock, and legacy Class B Common Stock have been retroactively restated to give effect to the Business Combination.